• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S NOVOPEN 6; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S NOVOPEN 6; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypoglycemia (1912)
Event Date 06/04/2022
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas) hypoglycemia [hypoglycaemia].Case description: study id: (b)(6).Study description: this is a multi-centre, prospective, single-arm, non-interventional clinical investigation, studying the glycaemic control in patients with type 1 diabetes when introducing a novopen 6 for treatment with tresiba (insulin degludec) and fiasp (fast-acting insulin aspart) in a real-world setting.Patient's height: 189 cm.Patient's weight: 90 kg.Patient's bmi: 25.19526330.This serious solicited report from (b)(6) was reported by a health care professional as "hypoglycemia(hypoglycemia)" beginning on (b)(6) 2022 and concerned a (b)(6) male patient who was treated with novopen 6 (insulin delivery device) on (b)(6) 2021, for "type1 diabetes mellitus".Current condition: type 1 diabetes mellitus ((b)(6) 1978), diabetic retinopathy ((b)(6) 1996), addison disease ((b)(6) 2012), hypertonia (2005), asthma bronchiale ((b)(6) 2010), sleep apnoe, ((b)(6) 2011) and hyperlipidemia ((b)(6) 2018).On (b)(6) 2022, patient experienced hypoglycemia with blood glucose values of 1.8 mmol/l and the patient required hospitalization for the same.The patient was discharged on the same date.Batch numbers of novopen 6 not reported.On (b)(6) 2022 the outcome for the event "hypoglycemia(hypoglycemia)" was recovered.Reporter's causality (novopen 6) - hypoglycemia(hypoglycemia) : probable.Company's causality (novopen 6) - hypoglycemia(hypoglycemia) : possible.This report is for a foreign device that is assessed as "similar" to us marketed novopen echo.Reporter comment: addison's disease reported as alternate aetiology for the event.
 
Event Description
Case description: reporter's causality (novopen 6) - hypoglycemia(hypoglycemia) : unlikely.Company's causality (novopen 6) - hypoglycemia(hypoglycemia) : unlikely.Since last submission the following information has been updated; -reporter causality of the event updated from probable/possible to unlikely/possible.-narrative updated accordingly.On 08-aug-2022, the causality assessment of the event 'hypoglycemia' was downgraded from 'probable/possible' to unlikely/possible' from the investigator.The case is considered as non-reportable as there is no casual relationship and no technical compliant reported with the novopen 6.The suspected device novopen 6 has not been returned to novo nordisk for evaluation.The case will not qualify as reportable device incident.
 
Event Description
Case description: investigation result: novopen 6.No investigation was possible, because neither sample nor batch number was available.Since last submission the following information has been updated; investigation result updated.Annex b, c, d and g codes updated.Malfunction field updated from 'yes" to "no".Narrative updated accordingly.The correct ird of the case was 04-aug-2022, however during triage step it was captured 08-aug-2022 by an error.This was identified during reconciliation.Hence an amr has been filed.Company comment: 24-aug-2022:the causality from the investigator updated from probable to unlikely related to novopen 6.The relevant information on technical complaint with novopen 6 is unavailable.The suspected device novopen 6 has not been returned to novo nordisk for evaluation.The case will not qualify as reportable device incident.H3 continued: evaluation summary.Novopen 6.No investigation was possible, because neither sample nor batch number was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 6
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S
bagsvaerd,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S
krogshoejvej 55
bagsvaerd, 2880
DA   2880
Manufacturer Contact
p.o. box 846
plainsboro, NJ 08536
8007276500
MDR Report Key14874912
MDR Text Key295049787
Report Number9681821-2022-00055
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
K123766
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age51 YR
Patient SexMale
Patient Weight90 KG
-
-